Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
fda
2
×
indiana blog main
life sciences
national blog main
new york blog main
type 1 diabetes
arrowmark partners
beta bionics
bigfoot biomedical
boehringer ingelheim
boston
boston blog main
boston top stories
boston university
congenital hyperinsulinism
deals
dexcom
diabetes
drug delivery
edward damiano
empagliflozin
europe
europe blog main
europe top stories
eventide asset management
indiana top stories
insulinoma syndrome
investing
lifesci venture partners
medical device
medtech
medtronic
new york top stories
novo nordisk
raleigh-durham blog main
roboticsai
rtw investments
What
diabetes
2
×
patients
2
×
approval
beta
bid
bionics
blood
boehringer
closed
developing
device
driven
drug
eli
expand
fallen
fda
heads
ingelheim
key
levels
lilly
manages
marketed
medical
medicine’s
million
monitors
pancreas
rejects
secures
short
startup
sugar
tests
type
Language
unset
Current search:
fda
×
patients
×
diabetes
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
